KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-Current Debt: 2011-2021

Historic Non-Current Debt for TherapeuticsMD (TXMD) over the last 5 years, with Sep 2021 value amounting to $171.7 million.

  • TherapeuticsMD's Non-Current Debt fell 27.55% to $171.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $171.7 million, marking a year-over-year decrease of 27.55%. This contributed to the annual value of $237.7 million for FY2020, which is 22.13% up from last year.
  • Per TherapeuticsMD's latest filing, its Non-Current Debt stood at $171.7 million for Q3 2021, which was down 2.01% from $175.3 million recorded in Q2 2021.
  • In the past 5 years, TherapeuticsMD's Non-Current Debt ranged from a high of $243.4 million in Q1 2020 and a low of $73.1 million during Q2 2018.
  • Over the past 3 years, TherapeuticsMD's median Non-Current Debt value was $194.2 million (recorded in 2019), while the average stood at $190.1 million.
  • In the last 5 years, TherapeuticsMD's Non-Current Debt spiked by 231.19% in 2020 and then fell by 27.55% in 2021.
  • Quarterly analysis of 4 years shows TherapeuticsMD's Non-Current Debt stood at $73.4 million in 2018, then surged by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020, then declined by 27.55% to $171.7 million in 2021.
  • Its Non-Current Debt stands at $171.7 million for Q3 2021, versus $175.3 million for Q2 2021 and $179.0 million for Q1 2021.